You searched for "infections"
Intravitreal dexamethasone implant for diabetic macular oedema
The authors report on the three-year outcomes of the Ozurdex Dexamethasone (DEX) intravitreal implant multi-centre trial for the treatment of diabetic macular oedema (DME). Patients with DME (best-corrected vision of 20/50 to 20/200 and central retinal thickness of ≥300µm) were...
Bleomycin for conjunctival lymphangioma
This is a retrospective review of 16 eyes which underwent intralesional / sub-conjunctival injections of bleomycin sclerotherapy for conjunctival lymphatic malformations (lymphangiomas). The mean age was 18 (range three to 59 years). Four of the lesions were microcystic and 12...
Treat and extend for PCV
This South Korean study investigated the efficacy of a treat and extend regimen (TER) using ranibizumab to treat polypoidal choroidal vasculopathy (PCV). Twenty-nine eyes were included in this retrospective case note review. Of these, five eyes had been treated with...
Botulinum toxin after orbicularis myectomy
This is a retrospective review of 27 patients with benign essential blepharospasm who had become resistant to treatment with botulinum toxin and had therefore undergone orbicularis myectomy of the upper lids. The study compares the dose and frequency of botulinum...
Switchover study from Botox to Xeomin for facial dystonia
This study carried out in the UK compared the clinical effectiveness and efficiency of switching patients from Botox® injections to Xeomin®. This was carried out in 20 essential blepharospasm, 12 hemifacial spasm and six aberrant facial nerve regeneration patients. Patients...Orbis marks 100-millionth antibiotic dose in the fight against trachoma in Ethiopia
Orbis and partners mark historic 100-millionth dose of azithromycin antibiotics in the fight to eliminate blinding trachoma in Ethiopia by 2030. This milestone was achieved 20 years after Orbis began leading mass drug administrations.Medical Ophthalmological Society (MOSUK) Meeting 2024
by Nima Ghadiri, Medical Ophthalmology Consultant and Honorary Senior Clinical Lecturer, Liverpool. Diseases at the interface between ophthalmology and systemic medicine are like chameleons, masterful in their ability to adapt and often challenging to diagnose. These conditions don't always present...RANZCO Congress 2025
The Royal Australian and New Zealand College of Ophthalmologists Annual Congress 2025
LR/SR surgery for high myopia strabismus
The authors evaluated the outcomes of a surgical procedure involving the muscle union of the superior rectus and lateral rectus muscles with and without medial rectus recession and the anatomic changes before and after surgery in 35 eyes of 20...
Type 3 CNV and anti-VEGF
The purpose of the study was to determine the differences between aflibercept and ranibizumab in terms of their therapeutic efficacy in the treatment of Type 3 neovascularisation. The authors highlight that the dominant mechanism for Type 3 neovascularisation development is...
Impact of WASH factors on trachoma prevalence
Trachoma is the leading infectious cause of blindness globally. Following a national population-based trachoma survey in Malawi, one round of azithromycin mass drug elimination (MDA) was carried out successfully – that is, the prevalence of trachomatous inflammation, follicular (TF) in...
